Health state profile data, such as those provided by the EQ-5D, are widely collected in clinical trials, population surveys, and a growing range of other important health sector applications. However, these profile data are difficult to summarize to give an overall view of the health of a given population that can be analyzed for differences between groups or within groups over time. A common way of short cutting this problem is to transform profiles into a single number, or index, using sets of weights, often elicited from the general public in the form of values. Are there any problems with this procedure? In this article, the authors demonstrate the underlying effects of the use of value sets as a means of weighting profile data. They show that any set of weights introduces an exogenous source of variance to health profile data. These can distort findings about the significance of changes in health between groups or over time.
Health state profile data, such as those provided by the EQ-5D, are widely collected in clinical trials, population surveys, and a growing range of other important health sector applications. However, these profile data are difficult to summarize to give an overall view of the health of a given population that can be analyzed for differences between groups or within groups over time. A common way of short cutting this problem is to transform profiles into a single number, or index, using sets of weights, often elicited from the general public in the form of values. Are there any problems with this procedure? In this article, the authors demonstrate the underlying effects of the use of value sets as a means of weighting profile data. They show that any set of weights introduces an exogenous source of variance to health profile data. These can distort findings about the significance of changes in health between groups or over time.
No set of weights is neutral in its effect. If a summary of patient-reported outcomes is required, it may be better to use an instrument that yields this directly (such as the EQ VAS) along with the descriptive instrument. If this is not possible, researchers should have a clear rationale for their choice of weights and be aware that those weights may exert a nontrivial effect on their analysis. This article focuses on the EQ-5D, but the arguments and their implications for statistical analysis are relevant to all health state descriptive systems. H ealth state data are widely collected in clinical trials, population surveys, and a growing range of other important applications in the health sector as indicators of people's health status. These data are derived from a variety of different measurement instruments, many of which describe health status in terms of its various attributes, such as pain and disability. Moving beyond description of health status to statistical analysis of health state data imposes requirements on the way that these data are presented, in particular, the need to construct from them an indicator that shows the direction and magnitude of differences in health status.
An important example of an instrument for measuring health status is the EQ-5D, developed by the EuroQol Group and intended for patient selfcompletion. 1 The standard EQ-5D self-report questionnaire comprises 2 parts: the EQ-5D selfclassifier, which uses the EQ-5D descriptive system, and the EQ VAS, which records an overall rating of health from 0 to 100 on a visual analogue scale. Together, these give valuable information on the health states of individuals, groups of patients, and populations. Common uses of the EQ-5D include comparisons of population health over time and between countries, monitoring the health of patient groups, and gauging the effectiveness and cost-effectiveness of treatments. In the United Kingdom, a number of other, more innovative uses of the EQ-5D have recently been proposed. From April 2009, patients' self-reported health improvement on the EQ-5D has been collected for use as a hospital performance indicator in the National Health Service (NHS), used to help patients choose which hospital to be referred to. 2 The EQ-5D has also been advocated for use in measuring the productivity and performance of the NHS. 3 The self-classifier provides health state profile data that categorize the respondent's health state according to the EQ-5D descriptive system, known as EQ-5D health states. Unlike the EQ VAS data, these data are not single numbers but a set of categorical variables recording the respondent's health as 1 of 3 levels (essentially no, some, or extreme problems) on each of 5 dimensions (mobility, self-care, usual activities, pain and discomfort, and anxiety and depression). Profiles therefore contain rich and detailed information on health states; unfortunately, it is hard to summarize them concisely and even harder to analyze them for statistical inference purposes.
Many studies have attempted to overcome this by converting the profile to a single index number, known as an EQ-5D index. Such an index is easy to summarize and is easily amenable to statistical inference techniques. It is constructed by applying weights to each of the levels within each dimension and adding these together for particular health states. However, although this is in some cases a valid procedure, in many it is not. The most obvious context in which an index is appropriate is cost-effectiveness analysis. 4 However, as will be explained in the next section of the article, there are many uses, both economic and noneconomic, in which it is not so obvious.
This article examines the statistical properties of EQ-5D indexes, exposing the underlying processes and assumptions, and offers recommendations to users of the EQ-5D regarding the collection and analysis of data. In particular, it examines the index in the context of statistical inference. Although our focus is on the EQ-5D, the issues we identify are relevant to any multidimensional health state classification system that seeks to provide an overall summary measure of health.
THE USES OF PROFILE DATA
EuroQol Group guidance on analyzing and reporting EQ-5D data 5 suggests that profile data should be reported as tables of frequencies and percentages of respondents having particular levels in particular dimensions. In the Group's publication on measuring self-reported population health, 6 descriptive data are presented as the percentage reporting each level in each dimension and summary statistics of EQ VAS ratings, with hypothesis testing restricted to the EQ VAS ratings. The EuroQol Web site gives similar examples on the page ''How to Report EQ-5D Results.'' 7 The Group gives no guidance on how profile data might be analyzed for statistical inference purposes, for example, testing for significant differences in health status between patient groups or for significant changes within groups over time. The most obvious descriptive technique to use for such categorical data would be contingency tables and tests of association, such as w 2 . However, there are 243 possible EQ-5D health states, and although this is small relative to many other health status instruments, it is large enough to mean that there are severe limitations on how useful these techniques can be. It is possible to examine each of the 5 dimensions separately for differences in the number of respondents in each level, requiring a 3 × 3 contingency table. Analyzing 5 such tables is quite feasible, but this does not provide an overall summary of the profile. If a complete profile is looked at, there is potentially a 243 × 243 contingency table, which is too cumbersome for any practical purposes. Of course, in practice, a large number of the potential states will not be found within real samples, but it is nevertheless unlikely to result in a small enough number to be analyzable. Furthermore, samples in which there are many small or empty cells will require categories to be collapsed to make the data amenable to analysis, resulting in a loss of information.
This problem is less acute if the EQ-5D is used in the way intended by the EuroQol Group, which is to use the complete EQ-5D self-report questionnaire. The EQ VAS provides an overall summary of selfreported health as a single number between 0 and 100, which can readily be presented in the form of summary statistics or graphs and used for undertaking statistical inference. However, in many applications, the EQ-5D self-classifier is used as a standalone measure, without the EQ VAS. Examples include the use of the EQ-5D in official surveys such as, in the United Kingdom, the Health Survey for England 8 and surveys of NHS hospital inpatients. 9 Analyzing EQ-5D profile data is also not problematic if they are to be used for cost-effectiveness analysis-the context in which health economists are most familiar with the use of the EQ-5D. The EQ-5D is one of the health outcome measures recommended by pharmaceutical reimbursement authorities in the Netherlands, New Zealand, Norway, Italy, Hungary, Poland, and Portugal. 10 The United Kingdom's National Institute for Health and Clinical Excellence states that ''to allow comparisons across technologies, the Institute requires that health states should be measured in patients'' and that ''currently, the most appropriate choice in the UK appears to be the EQ-5D.'' 11 In its application in cost-effectiveness analysis, an EQ-5D index is used as the quality-of-life element in the calculation of quality-adjusted life-years. The index reflects the utility or value of an EQ-5D health state, on a scale that has a maximum value of 1, representing full health; an anchor of 0, representing a state equivalent to being dead; and with states regarded as worse than being dead having a value lower than 0. These indexes have been developed by economists for a specific purpose and have a clear theoretical rationale that motivates their measurement and meaning.
The use of the EQ-5D in economic evaluation is facilitated by the existence of EQ-5D value sets, often called ''tariffs,'' in many countries, 10 which show the value of each and every possible health state. These have been generated by asking members of the general public to consider health states described by the EQ-5D, which they may or may not have experienced, and to value those states using techniques such as a visual analogue scale and time tradeoff (TTO). In the United Kingdom, the most widely used weights are TTO values from a UK population study known as the Measuring and Valuing Health (MVH) study. 12 More recently, a similar set of weights has been produced for the United States. 13, 14 However, what of applications of the EQ-5D other than in economic evaluation? The EQ-5D is now used in a wide range of applications in the health sector other than assessments of cost effectiveness (see Table 1 ).
Each of these applications confronts the challenge noted above: Given that EQ-5D profiles are not readily amenable to statistical analysis, how can overall health and changes in health be summarized and analyzed? One solution is to use exactly the same procedure used in economic evaluation and apply a set of weights to create a single index. In principle, this could be any set of weights, but in practice, the most common approach is to use the published value sets used in economic evaluation. Are there any problems in using this solution?
The EuroQol Group guidance to users of EQ-5D value sets 18 warns against using value sets to produce a single index for statistical analysis of profiles that are meant to be purely descriptive. This is because ''there is no 'neutral' set of weights that can be used for this purpose'' and ''no set of weights is objective.'' A neutral set of weights would be one that made no assumptions about the relative importance of the different levels and dimensions; an objective set of weights would be one that did not derive from someone's judgment about their relative importance. It advises that ''it may be better not to use an index, but to report the EQ-5D profiles themselves in some detail'' and ''where a single number is required to represent health . . . it may be more appropriate to focus on the EQ VAS data provided by the relevant patients or populations themselves . . . rather than applying social value sets to their EQ-5D profiles.'' 18(p40) However, the Group's guidance is not always followed. The report 19 that informed the UK Department of Health's introduction of routine use of the EQ-5D collected EQ-5D profiles and applied the MVH TTO value set to these to facilitate analysis. Similarly, the EQ-5D data collected by the Health Survey for England are summarized by application of the ''EuroQol tariff.'' 20 In both contexts, the data are explicitly meant to represent patient-or population-reported outcome measures, and there is no intention to interpret the numbers as values. Indeed, there are numerous published examples of EQ-5D profile data being converted into EQ index values in noneconomics applications, either instead of or in addition to analysis of the EQ VAS. In most cases, no clear rationale for doing so is provided by the authors. Recent examples include a study of the quality of life of diabetes patients, 21 a longitudinal study of population health in Sweden, 22 and a study of quality of life among stroke survivors. 23 It could be argued that some quality-of-life studies provide baseline data for subsequent economic evaluations. However, if studies do have that purpose, then that should be made clear. Moreover, the analysis and reporting should then be structured to provide that information in ways useful to future economic evaluations. This should include the separate reporting of health states and the values to be attached to them, as recommended by the US Public Health Panel on Cost-effectiveness in Health and Medicine, 24 which is consistent with the recommendation commonly found in guidelines for reporting economic evaluations that resource use should be separately reported from unit costs. 25 The EuroQol Group's guidance is mainly based on the disputed legitimacy of using for other purposes value sets that are applicable to economic evaluation. The value sets that are used for economic evaluation have a clear theoretical rationale that underpins the form of the weights, the way that they are derived, and their meaning. This rationale may not extend to other uses and indeed may be entirely out of keeping with them. The weights used in economic evaluation are explicitly regarded as values or utilities, with a quite narrow definition attached to them. There is a clear meaning attached to the values 1 and 0 and to values less than 0; it is desirable to use a recognized stated preference technique to obtain them; and there is a justification for the use of the general population as a source of weights. The resulting weights should be used in other applications only if the same theoretical rationale also applies.
Prieto and Sacristán 26 offered a contrasting view, which is that the weights really do not matter. They assert that most of the variation in an EQ-5D index is due to differences between respondents and that weights make little difference to that. They compared, for a large data set, an index weighted using the MVH values with one using equal weights for both levels and dimensions, finding mean values that differed by what they regarded as a negligible amount. They concluded that it is unnecessary to use social preference-based values rather than a simple set of weights.
But there is another relevant question about the use of weights: What are the statistical properties of the resulting index? One issue is that although the weights are treated as fixed coefficients, they are in fact themselves estimates derived from a sample and therefore have a sample distribution that ought to be taken into account in any statistical inference. Because statistical testing of the index tests both the profile data and the weights, we speculate that some account ought to be taken of the variability of the weights. Unfortunately, as this will be derived from a completely different sample, it is not obvious how this might be undertaken. The issue of how variability in weights affects statistical analysis is a complex question that is not dealt with in this article. We look at another issue, which applies whether or not weights are fixed: how adding weights to profile data affects statistical inferences made about the resulting index.
A DECOMPOSITION OF THE EQ-5D INDEX
It is important to remember that we are interested in the EQ-5D index as a summary of a set of EQ-5D From 2009, National Health Service (NHS) hospitals have had a requirement to measure patients' self-reported health before and after surgery, using the EQ-5D and a condition-specific instrument, for all patients undergoing 5 surgical procedures 2 ; the EQ-5D has also been included in past NHS surveys of inpatients 9 profile data, referring to a particular patient or population group. Any EQ-5D index, whatever the source and structure of its weights, is made up of not only the profile data under analysis but also another data set made up of the weights that are used to convert the profile data into a single number. It is useful to analyze the role of each of these data sets in determining the numbers that are calculated for the index, and we will therefore decompose the index into its separate constituents. The usual procedure for calculating an EQ-5D index is first to convert the profile data into a set of binary variables. The most important of these binary variables are derived from the categorical variables that describe the levels of each dimension of the EQ-5D. As described, each dimension of the EQ-5D has 3 levels: no problems, some problems, and extreme problems. Two binary variables can therefore be used for each dimension: the presence or absence of the ''some problems'' level, which we will refer to as level 2, and the presence or absence of the ''extreme problems'' level, which we will refer to as level 3. The absence of both of these indicates no problems, or level 1. As there are 5 dimensions, there are 5 × 2 = 10 binary variables of this kind.
There may also be other binary variables that represent interaction effects between dimensions and levels. Two widely used interaction variables of this kind are one that records the presence of any level 2 or level 3 state, referred to as a constant because of its derivation from a regression equation, and another that records the presence of any level 3 health state, referred to as N3, a term used in the MVH study. 12 Weighting the profile data to create an index therefore in practice means attaching weights to these binary variables. In what follows, it is assumed that for each binary variable, 0 represents the absence of a level within a dimension or an interaction, and 1 represents its presence. Let H j = Index score 1 for individual j b i ¼ Binary variables representing levels within dimensions w i ¼ Index weights for binary variable b i Then
In this formulation, no constraints are placed on the numeric values given to the index weights or the index scores because, as will be shown, this has no impact on inference issues. Nevertheless, it does raise an important issue, because for most applications using health status information, we will be interested in absolute values of the index, of differences in the index between different groups, and of changes within groups over time. In clinical studies, for example, knowing the absolute value of the effect size is as important as knowing whether or not it is significantly different from zero. For that reason, it is not enough simply to have weights that describe the relative importance of different levels and dimensions.
In what follows, we will examine the problems that arise in statistical testing of the mean of this index, in particular, comparing differences in its value for 2 population or patient groups. However, it should be noted that the same problems will arise in calculating and making inferences about other statistics, for example, correlation coefficients, and therefore tests of association as well as tests of difference.
To test for differences in the value of the index requires us to know its mean and variance. Because the individual values of the index are calculated from the values of the binary variables and the weights, it follows that the mean and variance of the index must also be a function of these 2 elements. In fact, the mean and variance of H turn out to have fairly obvious relationships with the corresponding statistics for the binary variables.
Mean of the Index
It can be shown that
The mean value of H j is therefore a weighted sum of the means of the binary variables, using the same weights and weighting structure as for the individual values of H j . What does this mean value tell us? If the binary variables are indicators of the presence or absence of a particular level in a particular dimension, then their mean values are simply the proportions of the sample with that level in that dimension. The mean value of H j is in effect a summary of these proportions over all levels and dimensions, weighting the relative importance attached to them. This seems a reasonable thing to do, if the weights are appropriate to the task. However, it is important to recognize that the mean value is determined by both the data that directly describe the sample (the profile data) and data that are generated externally to the sample (the weights). It is equally accurate to describe the mean value of the index as a set of constant values (the w i ) that are weighted by the relative proportions observed in a particular sample or population.
The addition of variables such as N3 and the constant complicates this slightly. It is arguably justified to include these if the index is regarded as measuring a concept of health in which the simple binary variable weightings do not fully capture the relative importance of different levels and dimensions. However, users of the index who mean it merely to be a descriptive summary ought to be aware of the weight structure that they are building in and its origins. Most of the widely used value sets are derived from regression analyses conducted on an entirely different type of data-valuations of described health states-taken from a completely separate sample or population; the interaction variables are included solely to improve the statistical properties of the regression equation.
Variance of the Index
Again, it can be shown that
The variance of H j is a weighted sum of both the variance of each binary indicator and the covariance between each binary indicator, again using the index weights. It cannot be expressed as a function simply of the variances. The interpretation of the term in equation 3 that includes the variances of the binary variables is quite straightforward. The variance of a binary variable is the proportion of ones in the data multiplied by the proportion of zeroes; because the proportion of ones is the mean, the variance is
The covariance term is more complicated. The covariance of 2 binary variables is the proportion of cases in the data where both variables take the value 1, which is the mean of their products, minus the product of the proportion of each that takes the value 1, which is the product of their means. The covariance is therefore
This is complicated by the fact that the b i include indicators representing different levels within a single dimension. Where this is the case, the first term in the covariance definition will be zero and the covariance must therefore be negative. The covariance term introduces interactions not only between the different levels and dimensions of the data but also between the weights-the w i w l terms. In general, the variance for H j is a complex function not only of variance and covariance terms but also of the weights. Expressed in terms of means of the binary variables, the variance in equation 3 becomes
Testing for Differences between Means
For simplicity, let us assume that we are conducting a test of the differences in H between two groups X and Y with the same sample size, n. The means for populations X and Y are
The difference in means can be shown to be
The difference in means is therefore a linear weighted sum of the difference in means of the binary variables, in other words, of the difference between the proportions of the 2 samples having each level in each dimension. This definition and STATISTICAL ANALYSIS OF EQ-5D PROFILES
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those of the individual index numbers and their mean value are symmetrical.
The variance of this difference is
Var
which can also be expressed as
The variance of the difference in means is again a nonlinear weighted function of the variances and covariances. This definition and that of the variance are symmetrical. The appropriate test statistic for a normally distributed variable with unknown population standard deviation is the t statistic:
If we substitute expressions 5 and 6 (or 7) and 8, it is apparent that the numerator of expression 8 is linear in weights, but the denominator is nonlinear and complex. The weights do not, except for an important exception noted below, cancel out, and they are therefore an important determinant of the value of the t statistic. The consequence is that the weights chosen may determine statistical significance; different sets of weights may give different conclusions about whether or not 2 groups are significantly different from each other. As suggested earlier, the same problem would occur if other statistical procedures are carried out, such as tests of association using correlation coefficients.
This problem is, however, restricted to sets of weights that differ in their relative, not simply their absolute, values. The relative values of a set of weights are the ratios of each weight for a level within a dimension to every other weight. For example, the weight for level 3 pain may be twice as large as that of level 2 pain, the weight for level 2 anxiety may be twice that of level 2 self-care, and so on for all possible dimensions and levels. The absolute values are the actual numeric values of the weights, for example, 0.5 for level 2 usual activities, 0.8 for level 3 anxiety, and so on. Suppose that we have 2 sets of weights for which the relative values are the same for every level in every dimension, but 1 set of weights has absolute values twice as large as the other. So, although the weight of level 3 pain is 3 times as large as that of level 2 pain in each case, 1 set of weights has absolute values of 0.3 and 0.9, respectively, for these and the other has 0.6 and 1.8. This can be represented as a scalar l, in this case 2, applied to each w i . Examining equations 2 and 5, it is apparent that this will result in H becoming l HZ and (
Similarly, from equations 3 and 6, σ 2 H will become l 2 σ 2 H and Var
l will therefore cancel out in equation 8, so that the value of t for 2 sets of weights is not affected by differences in their absolute values, if their relative values are the same.
Finally, it may be noted that the weights disappear from equation 8 if they are all equal, giving the t test as
This emphasizes that the absolute values do not matter in significance testing, because obviously the result in equation 9 will be the same whatever value the equal weight has.
A Simulated Empirical Example
To demonstrate the conclusions of our analysis, a simple simulation was performed. The procedure was as follows:
1. Generate a random sample of 100 from the 243 possible EQ-5D health states, without replication (group 1). 2. Generate an identical set of data, except for 5 of the health states chosen at random, which are changed to give a 1-level improvement in 1 dimension of the EQ-5D (group 2). 3. Apply different sets of weights to the resulting data.
Each set of weights is applied equally to the 2 groups to generate an index score for each. 4. Calculate paired-comparison t tests of the differences in the index scores of group 1 and group 2 for each set of weights.
Because of their widespread use in the United Kingdom and elsewhere, the MVH weights were chosen as one of the comparators. It is possible to compare these directly with 2 other published sets of weights, based on data from the Netherlands 27 and Spain. 28 There are several other TTO-based sets available, but these have a slightly different structure (e.g., no N3 variable for weights from Denmark, Japan, the United States, and Zimbabwe). 10 Our conclusions apply equally to the use of these sets of weights and to others based on other valuation methods, but to make a clean comparison, we focus on the 3 sets that are identically structured and derived.
To explore in more detail how different relative weights affect inference, we also examined 9 artificial sets of weights. Four of these had equal weights for each of the dimensions but different weights for the levels within each of them. As explained, the binary variables represent the presence or absence of level 2 and level 3 responses within a dimension. A higher weight was given to level 3 by multiplying the level 2 by a constant. Four different multipliers were used: 2, 3, 4, and 10. The other 5 sets had different weights for each level in different dimensions. This was achieved by adding a constant absolute increment to both weights within a dimension, so that, for example, 0.005 is added to the level 2 and level 3 weights for mobility to obtain those for self-care, 0.01 is added to obtain those for usual activities, and 0.015 and 0.02 are added to obtain those for pain/discomfort and anxiety/depression, respectively. Using the same increment, 2 different multipliers, 4 and 5, were used for the relative weights for levels. In each case, the resulting weights were applied first to the dimensions in the order in which they appear in the EQ-5D questionnaire and then to the dimensions in a random order. The final set of weights was for a higher increment, 0.01.
These numbers used as multipliers and increments were chosen to produce mean values comparable with those arising from the MVH weights. That is an arbitrary criterion, and it is therefore not meaningful to compare the actual mean values. However, as explained, the absolute values do not affect the results in terms of t and P values. So, to prevent any misleading comparisons, Table 2 reports the P values for a 2-tailed paired-comparison test for each set of weights but does not report any of the means and standard deviations. Table 2 shows that when using the UK and Spanish weights, the t test detected a significant difference in the means at the 5% level, although with quite different P values. Using the Netherlands weights, however, suggests that the means are not significantly different at the 5% level. Where weights were assumed equal for each dimension, the P value depended on the relative size of the weights for level 2 and level 3. The greater the difference in the weights between levels, the higher the P value. Relative weightings of 3 and below generated a significant difference at the 5% level; those 4 and higher an insignificant difference.
Where weights were unequal between dimensions, the same result held; in addition, the greater the difference in weights between dimensions, the lower the P value. The interaction between the weighting structure and the data was also an important determinant of the P value. If the weights for different dimensions were switched, the P value changed, and in 1 of the examples, this resulted in a change from significance to nonsignificance. A set of weights that is of particular interest is the one labeled ''Equal weights dimensions; Level3 = 2*Level2,'' which produces the lowest P value among the comparisons here. This corresponds to what might be called an equally weighted index of a kind often found in clinical studies, in which the levels within dimensions are ranked and the rank numbers are summed over all dimensions to give a score. The t test used here therefore corresponds to that given by equation 9. Choosing an equally weighted index therefore gives the greatest chance of finding a statistically significant difference between the 2 groups.
We therefore find that our theoretical results are both correct and of some practical importance. The t test is sensitive to weights, and therefore a test of differences in the means of the health index between groups tests not only differences that arise from the groups but also differences between the weights. Another way to view this is that there is, for a given sample size, a value of t for a given set of weights that is simply modified by the data. There must be some doubt, therefore, about whether the levels of significance that are implied by the test are in fact appropriate for this kind of data.
CONCLUSIONS
An alarming conclusion from our empirical analysis is that clinical trials carried out in the United Kingdom and the Netherlands that produce exactly the same EQ-5D data might lead researchers to make completely different statistically based conclusions about the effectiveness of the intervention being studied. Many countries do not have weights of their own and therefore have to use foreign weights; whether or not an intervention is seen as effective in such a country might depend on which other country's weights it chooses.
The problem of using an index created from weighted profile data is that any statistical analysis is affected by information that is not inherent to the sample data; variations in the index reflect variations not only in the sample but also in the weights. Statistical tests of significance also introduce complexities into the weighting system via the variance, in particular, interactions between weights, levels, and dimensions that are not in the original weighting structure. This may have the uncomfortable implication that conventional significance tests are inappropriate and give misleading levels of significance. This is most obviously an issue where the index is intended as a convenient summary of descriptive data, but the problem will also apply where it is intended as a value or utility, unless the underlying weights can be regarded as fixed. If they are regarded as variable, this casts some doubt on the results from very many published cost-effectiveness studies.
The main conclusion from this analysis is to reinforce the recommendation that applying sets of weights to profile data to produce an index should not be used as a short-cut method of summarizing profile data and of facilitating statistical inference from such data. It is only justifiable to create and make inferences from an index where the weights have specifically been created to produce a meaningful value relevant to the purpose for which the data are being used, which will represent some concept of what health is. This need not be value in the economic sense; it could, for example, represent a clinical view of the severity or burden of illness. For inference purposes, all that are then needed are weights that represent the relative importance of different dimensions and levels of health, although producing numbers that are meaningful in an absolute sense requires much more. If the weights used in an index have simply been imported and are not relevant to the purpose for which they are used, using that index is at best misguided and at worst misleading.
